Infectious Disease Archives | Page 2 of 6 | Certara

Publication

Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations

CertaraApril 1, 2018

Publication

Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

CertaraApril 1, 2018

Blog

Using a Pharmacology to Payer Framework to Support Product Development

Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…

CertaraMarch 16, 2018

Publication

Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics

CertaraMarch 1, 2018

Publication

Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial

CertaraJanuary 15, 2018

Publication

Model-informed Drug Development for Malaria Therapeutics

CertaraJanuary 6, 2018

Publication

Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology and Health Economics to Inform Antiviral Use in Pandemics

CertaraJuly 1, 2017

Publication

Isoniazid Clearance is Impaired Among Human Immunodeficiency Virus/Tuberculosis Patients with High Levels of Immune Activation

CertaraApril 1, 2017

Publication

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

CertaraJanuary 10, 2017

Publication

Limitations of MIC as Sole Metric of Pharmacodynamic Response Across the Range of Antimicrobial Susceptibilities within a Single Bacterial Species

The minimum inhibitory concentration (MIC) of an antimicrobial drug for a bacterial pathogen is used…

CertaraDecember 1, 2016

© 2025 Certara. All Rights Reserved. | Privacy policy